The Role of Eosinophils in Myocarditis

  • C. J. F. Spry
  • P.-C. Tai
  • J. Davies
  • E. G. J. Olsen
  • J. F. Goodwin
Conference paper

Abstract

The association of a persistent blood eosinophilia with the development of endomyocardial disease (eosinophilic endomyocardial disease) is now well described, and it has been suggested that eosinophils themselves may be involved in tissue injury leading to chronic heart disease [6]. It has also been suggested that tropical endomyocardial disease, in which a peripheral blood eosinophilia is less marked, may also be due to a toxic effect of eosinophilis on heart muscle [2]. Other forms of heart disease in which eosinophils are prominent include parasitic [1], granulomatous [3] and hypersensitivity disorders [9], which usually present as an acute systemic illness.

Keywords

Toxicity Leukemia Cardiomyopathy Cardiol Vasculitis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Andy JJ, O’Connell JP, Daddario RC, Roberts WC (1977) Trichinosis causing extensive ventricular mural endocarditis with superimposed thrombus. Evidence that severe eosinophilia damages endomyocardium. Am J Med 63: 824–829PubMedCrossRefGoogle Scholar
  2. 2.
    Brockington IF, Luzzatto L, Osunkoya BO (1970) The heart in eosinophilic leukemia. Afr J Med Sei 1: 343–352Google Scholar
  3. 3.
    Churg J, Strauss L (1951) Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 27: 277–301PubMedGoogle Scholar
  4. 4.
    Davies J, Spry CJF, Sapsford R, Olsen EGJ, DuPerez G, Oakley CM, Goodwin JF (1983) Cardiovascular features of eleven patients with eosinophilic endomyocardial disease. Q J Med 52: 23–39PubMedGoogle Scholar
  5. 5.
    Davies J, Spry CJF, Vijararaghavan G, deSouza JA (1983) A comparison of the clinical and cardiological features of endomyocardial disease in temperate and tropical regions. Postgrad Med J 59: 51–55Google Scholar
  6. 6.
    Olsen EGJ, Spry CJF (1977) The pathogenesis of Löffler’s endomyocardial disease, and its relationship to endomyocardial fibrosis. Prog Cardiol 8: 281–303Google Scholar
  7. 7.
    Shapiro LG (1919) Eosinophilic (polymorphonuclear) leukemia. Proc NY Pathol Sci 19: 73–83Google Scholar
  8. 8.
    Spry CJF, Davies J, Tai P-C, Olsen EGJ, Oakley CM, Goodwin JF (1983) Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med 52: 1–22PubMedGoogle Scholar
  9. 9.
    Spry CJF (1980) Eosinophilia and allergic reaction to drugs. Clin Haematol 9: 521–534PubMedGoogle Scholar
  10. 10.
    Spry CJF, Tai P-C, Davies J (1982) Eosinophils and endomyocardial fibrosis. Contrib Microbiol Immunol 7: 212–217Google Scholar
  11. 11.
    Tai P-C, Hayes DJ, Clark JB, Spry CJF (1982) Toxic effects of eosinophil secretion products on isolated rat heart cells in vitro. Biochem J 204: 75–80PubMedGoogle Scholar
  12. 12.
    Tai P-C, Holt M, Gibbs AM, Williams BD, Spry CJF (to be published) The deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis - the Churg and Strauss syndrome.Google Scholar
  13. 13.
    Tai P-C, Spry CJF, Peterson C, Venge P, Olsson I (to be published) Activated and degranulating human eosinophils defined with monoclonal antibodies.Google Scholar
  14. 14.
    Venge P, Stromberg A, Braconier JH, Roxin LE, Olsson I (1978) Neutrophils and eosinophil granulocytes in bacterial infection: sequential sections of cellular and serum levels of granule proteins. Br J Haematol 38: 475–483PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • C. J. F. Spry
  • P.-C. Tai
  • J. Davies
  • E. G. J. Olsen
  • J. F. Goodwin

There are no affiliations available

Personalised recommendations